MedPath

B.Braun Avitum AG

🇩🇪Germany
Ownership
-
Established
1839-01-01
Employees
-
Market Cap
-
Website
http://www.bbraun.com/

Clinical Trials

5

Active:0
Completed:4

Trial Phases

1 Phases

Not Applicable:4

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials

Not Applicable
4 (100.0%)

Prospective, Multicentre, Randomized, Controlled, Cross-over Study on the Safety and Performance of the Biologic Fusion Option of DialogiQ Compared to Haemodialysis Without Biologic Fusion in Hypotension Prone Patients on Maintenance Haemodialysis

Not Applicable
Recruiting
Conditions
Renal Dialysis
First Posted Date
2024-04-22
Last Posted Date
2024-04-29
Lead Sponsor
B.Braun Avitum AG
Target Recruit Count
56
Registration Number
NCT06376968
Locations
🇮🇹

Policlinico S. Orsola - Malpighi - UOC Nefrologia, Dialisi e Ipertensione, Bologna, Emilia Romagna, Italy

Determination In-vivo KUF for Diacap Pro Hemodialyser

Not Applicable
Completed
Conditions
Renal Insufficiency,Chronic
Kidney Disease, End-Stage
Kidney Insufficiency
Kidney Failure,Chronic
First Posted Date
2016-11-16
Last Posted Date
2017-02-07
Lead Sponsor
B.Braun Avitum AG
Target Recruit Count
12
Registration Number
NCT02964429
Locations
🇨🇿

Interní oddělení Strahov VFN, Praha, Czech Republic

Interdialytic Kt/V Variability Measurement With Adimea (IVP STUDY)

Completed
Conditions
Kidney Disease
First Posted Date
2013-09-23
Last Posted Date
2016-11-23
Lead Sponsor
B.Braun Avitum AG
Target Recruit Count
120
Registration Number
NCT01947829
Locations
🇨🇳

Beijing Friendship Hospital,Capital Medical University, Beijing, China

🇨🇳

China PLA General Hospital (301 hospital), Beijing, China

HELP Therapy for Dry AMD

Not Applicable
Completed
Conditions
Non-exudative (Dry) Age-related Macular Degeneration (AMD)
First Posted Date
2013-04-26
Last Posted Date
2016-11-23
Lead Sponsor
B.Braun Avitum AG
Target Recruit Count
22
Registration Number
NCT01840683
Locations
🇨🇦

Canadian Centre for Advanced Eye Therapeutics Inc., Mississauga, Ontario, Canada

Determination of in Vivo Ultrafiltration Coefficient (KUF) in Patients With Chronic Kidney Disease (CKD)

Not Applicable
Completed
Conditions
Kidney Disease
First Posted Date
2010-04-27
Last Posted Date
2012-03-14
Lead Sponsor
B.Braun Avitum AG
Target Recruit Count
12
Registration Number
NCT01111266
Locations
🇩🇪

Georg-Haas Dialysezentrum der PHV, Gießen, Hessen, Germany

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.